Tahseen Mozaffar
Neurology | Neuromusculoskeletal Medicine
200 South Manchester Avenue
Suite 110
Orange, CA 92868
Suite 110
Orange, CA 92868
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
Journal: The New England journal of medicine
Published: March 30, 2026
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
Journal: The New England journal of medicine
Published: March 30, 2026
Natural history of limb girdle muscular dystrophy R1 (LGMDR1): a GRASP consortium study.
Journal: Neuromuscular disorders : NMD
Published: December 10, 2025
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.
Journal: Arthritis care & research
Published: December 08, 2025
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.
Journal: Arthritis care & research
Published: December 08, 2025
The Mythology of Polymyositis.
Journal: Rheumatic diseases clinics of North America
Published: October 29, 2025
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the Future.
Journal: Rheumatic diseases clinics of North America
Published: October 29, 2025
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial.
Journal: Nature medicine
Published: October 24, 2025
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis.
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis.
Journal: Annals of clinical and translational neurology
Published: July 05, 2025
Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.
Journal: Therapeutic advances in rare disease
Published: July 02, 2025
Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.
Journal: Neurology. Genetics
Published: June 10, 2025
Last Updated: 09/26/2026